ScoreWhy is Procter & Gamble Health Ltd ?
1
High Management Efficiency with a high ROE of 36.14%
2
Company has a low Debt to Equity ratio (avg) at 0 times
3
Poor long term growth as Net Sales has grown by an annual rate of 6.67% and Operating profit at 12.79% over the last 5 years
4
Flat results in Sep 25
- DEBTORS TURNOVER RATIO(HY) Lowest at 0.93 times
5
With ROE of 49.5, it has a Very Expensive valuation with a 15.6 Price to Book Value
- The stock is trading at a discount compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of 2.70%, its profits have risen by 31.9% ; the PEG ratio of the company is 1
6
High Institutional Holdings at 21.15%
- These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to P & G Health Ltd should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is P & G Health Ltd for you?
Medium Risk, Medium Return
Absolute
Risk Adjusted
Volatility
P & G Health Ltd
2.7%
0.12
23.10%
Sensex
4.81%
0.41
11.83%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
6.67%
EBIT Growth (5y)
12.79%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
Net Debt is too low
Net Debt to Equity (avg)
-0.45
Sales to Capital Employed (avg)
1.80
Tax Ratio
24.81%
Dividend Payout Ratio
214.75%
Pledged Shares
0
Institutional Holding
21.15%
ROCE (avg)
87.52%
ROE (avg)
36.14%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
32
Industry P/E
34
Price to Book Value
15.65
EV to EBIT
23.99
EV to EBITDA
22.69
EV to Capital Employed
27.71
EV to Sales
7.33
PEG Ratio
0.99
Dividend Yield
2.14%
ROCE (Latest)
115.53%
ROE (Latest)
49.51%
Loading Valuation Snapshot...
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
No Trend
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend5What is working for the Company
PAT(9M)
At Rs 215.90 cr has Grown at 34.51%
CASH AND CASH EQUIVALENTS(HY)
Highest at Rs 2,861.70 cr
-2What is not working for the Company
DEBTORS TURNOVER RATIO(HY)
Lowest at 0.93 times
Loading Valuation Snapshot...
Here's what is working for P & G Health Ltd
Profit After Tax (PAT) - Latest six months
At Rs 154.72 cr has Grown at 35.78%
Year on Year (YoY)MOJO Watch
Near term PAT trend is positive
PAT (Rs Cr)
Cash and Cash Equivalents - Half Yearly
Highest at Rs 2,861.70 cr
in the last six half yearly periodsMOJO Watch
Short Term liquidity is improving
Cash and Cash Equivalents
Here's what is not working for P & G Health Ltd
Debtors Turnover Ratio- Half Yearly
Lowest at 0.93 times
in the last five half yearly periodsMOJO Watch
Company's pace of settling its Debtors has slowed
Debtors Turnover Ratio
Non Operating Income - Quarterly
Highest at Rs 4.95 cr
in the last five quartersMOJO Watch
Increased income from non business activities may not be sustainable
Non Operating Income
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
